Europe
There’s plenty of news related to clinical trials related to COVID-19, but it does seem to be drowning out non-COVID-19-related clinical trials. Here’s a look.
Swiss pharma giant Roche is joining the race to develop a test for COVID-19 antibodies in people who have been exposed to the disease.
GenSight Biologics, a biopharma company focused on discovering and developing innovative gene therapies for retinal neurodegenerative diseases and central nervous system disorders, announces the completion of the pre-submission meeting with the European Medicines Agency for the Company’s lead product LUMEVOQ®.
The Regenstrief Institute and Indiana University are launching a survey to conduct research about COVID-19 symptoms.
The discovery that immune T cells have a spectrum of responsiveness could shed light on how our immune system responds to infections and cancer, and what goes wrong in immune diseases.
Pharma and life sciences companies boost their executive ranks and boards with this week’s Movers & Shakers.
The two companies will evaluate a smartphone-based self-testing solution for COVID-19, using Luminostics’ innovative technology and Sanofi’s clinical research abilities.
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for April 16, 2020.
“It is always great to work with the forward-thinking leaders in cell and gene therapy, like Achilles, who are focused on innovating across the board, not just clinically and scientifically but also technologically. We see huge potential for the future of this partnership,” said Farlan Veraitch, Co-Founder and CSO, Ori Biotech.
Global pharma and life sciences companies provide updates on their business operations and pipelines.
PRESS RELEASES